NCT00366041View on ClinicalTrials.gov

Efficacy and Tolerance of Cellularised LG002 Versus Uncellularised LG002 in the Treatment of Severe Burns Injuries

PHASE2TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
Burns
Interventions
DRUG

Dermal substrate cellularised LG002 (10x10cm)

application depending on burn injury surface

DEVICE

Dermal substrate uncellularised LG002 (10x10 cm)

depending on burn injury surface

Trial Locations (2)

75679

Hôpital Cochin, Service des Brûlés, Paris

92141

Hôpital d' Instruction des Armées de Percy, Service des Brûlés, Clamart

Sponsors
All Listed Sponsors
collaborator

Hôpital d'Instruction des Armées de Percy

UNKNOWN

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Laboratoires Genévrier

INDUSTRY

NCT00366041 - Efficacy and Tolerance of Cellularised LG002 Versus Uncellularised LG002 in the Treatment of Severe Burns Injuries | Biotech Hunter | Biotech Hunter